Human mutations in LRP5 and SOST (sclerostin) alter WNT signaling and cause osteoporosis-pseudoglioma syndrome (OPPG) and van Buchem disease. This evidence concerns the gene LRP5 and osteoporosis-pseudoglioma syndrome.